The IARC TP53 database: New Online mutation analysis and recommendations to users

被引:1093
作者
Olivier, M
Eeles, R
Hollstein, M
Khan, MA
Harris, CC
Hainaut, P
机构
[1] Int Agcy Res Canc, Mol Carcinogenesis Grp, WHO, F-69372 Lyon, France
[2] Inst Canc Res, Canc Genet Team, Surrey, England
[3] German Canc Res Ctr, D-6900 Heidelberg, Germany
[4] NCI, Human Carcinogenesis Lab, NIH, Bethesda, MD 20892 USA
关键词
TP53; p53; mutation analysis; database; Li-Fraumeni syndrome; LFS; cancer; tumor suppressor;
D O I
10.1002/humu.10081
中图分类号
Q3 [遗传学];
学科分类号
071007 [遗传学]; 090102 [作物遗传育种];
摘要
Mutations in the tumor suppressor gene TP53 are frequent in most human cancers. Comparison of the mutation patterns in different cancers may reveal clues on the natural history of the disease. Over the past 10 years, several databases of TP53 mutations have been developed. The most extensive of these databases is maintained and developed at the International Agency for Research on Cancer. The database compiles all mutations (somatic and inherited), as well as polymorphisms, that have been reported in the published literature since 1989. The IARC TP53 mutation dataset is the largest dataset available on the variations of any human gene. The database is avail, able at wwwdarc.fr/P53/. In this paper, we describe recent developments of the database. These developments include restructuring of the database, which is now patient-centered, with more detailed annotations on the patient (carcinogen exposure, virus infection, genetic background). In addition, a new on,line application to retrieve somatic mutation data and analyze mutation patterns is now available. We also discuss limitations on the use of the database and provide recommendations to users.
引用
收藏
页码:607 / 614
页数:8
相关论文
共 13 条
[1]
Mutation analysis of the CHK2 gene in families with hereditary breast cancer [J].
Allinen, M ;
Huusko, P ;
Mäntyniemi, S ;
Launonen, V ;
Winqvist, R .
BRITISH JOURNAL OF CANCER, 2001, 85 (02) :209-212
[2]
Heterozygous germ line hCHK2 mutations in Li-Fraumeni syndrome [J].
Bell, DW ;
Varley, JM ;
Szydlo, TE ;
Kang, DH ;
Wahrer, DCR ;
Shannon, KE ;
Lubratovich, M ;
Verselis, SJ ;
Isselbacher, KJ ;
Fraumeni, JF ;
Birch, JM ;
Li, FP ;
Garber, JE ;
Haber, DA .
SCIENCE, 1999, 286 (5449) :2528-2531
[3]
p53 gene mutation:: software and database [J].
Béroud, C ;
Soussi, T .
NUCLEIC ACIDS RESEARCH, 1998, 26 (01) :200-204
[4]
GREENBLATT MS, 1994, CANCER RES, V54, P4855
[5]
Hainaut P, 2000, ADV CANCER RES, V77, P81
[6]
Sources of bias in the detection and reporting of p53 mutations in human cancer: analysis of the IARC p53 mutation database [J].
Hernandez-Boussard, T ;
Montesano, R ;
Hainaut, P .
GENETIC ANALYSIS-BIOMOLECULAR ENGINEERING, 1999, 14 (5-6) :229-233
[7]
Hernandez-Boussard T, 1999, HUM MUTAT, V14, P1
[8]
HOLLSTEIN M, 1994, NUCLEIC ACIDS RES, V22, P3551
[9]
p53 mutation spectrum and load:: the generation of hypotheses linking the exposure of endogenous or exogenous carcinogens to human cancer [J].
Hussain, SP ;
Harris, CC .
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS, 1999, 428 (1-2) :23-32
[10]
P53 AND THE LI-FRAUMENI SYNDROME [J].
MALKIN, D .
CANCER GENETICS AND CYTOGENETICS, 1993, 66 (02) :83-92